COPD A Guide to Diagnosis and Clinical Management
Chronic obstructive pulmonary disease (COPD) affects millions of people across the world. COPD is not only a major burden to patients but is also costly and results in billions of dollars of direct and indirect costs annually. In recent years and with adv
- PDF / 7,735,088 Bytes
- 324 Pages / 527.76 x 737.188 pts Page_size
- 23 Downloads / 264 Views
Nicola A. Hanania Amir Sharafkhaneh Editors
COPD A Guide to Diagnosis and Clinical Management
Respiratory Medicine Series Editor: Sharon I.S. Rounds
For futher volumes: http://www.springer.com/series/7665
wwwwwwwwwww
Nicola A. Hanania • Amir Sharafkhaneh Editors
COPD A Guide to Diagnosis and Clinical Management
Editors Nicola A. Hanania Baylor College of Medicine Section of Pulmonary and Critical Care Medicine 1504 Taub Loop Houston, TX 77030, USA [email protected]
Amir Sharafkhaneh Baylor College of Medicine Michael E. DeBakey VA Medical Center 2002 Holcombe Blvd. Houston, TX 77030, USA
[email protected]
ISBN 978-1-58829-949-9 e-ISBN 978-1-59745-357-8 DOI 10.1007/978-1-59745-357-8 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2010935948 © Springer Science+Business Media, LLC 2011 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein Printed on acid-free paper Humana Press is part of Springer Science+Business Media (www.springer.com)
We dedicate this work to all our COPD patients who continue to teach us every day and to our primary care colleagues who are in the forefront of managing these patients.
wwwwwwwwwww
Preface
Chronic obstructive pulmonary disease (COPD) affects millions of people across the world. Cigarette smoking and/or exposure to other noxious stimuli results in inflammation and damage to the airways and lung parenchyma, resulting in expiratory flow limitation. COPD is not only a major burden to our patients but is also costly and results in billions of dollars of direct and indirect costs annually. In recent years and with advancement of science, our understanding of COPD improved significantly. Current management guidelines consider COPD as a “…preventable and treatable…” condition. Recent studies clearly indicate that available pharmacological and non-pharmacological interventions may improve various clinical outcomes in patients with COPD. This book was written to help clinicians who take care of patients with COPD
Data Loading...
